Tempus Oncology is a precision medicine company that leverages AI and vast clinical and molecular data to support oncologists in making data-driven treatment decisions. Its offerings include comprehensive genomic profiling, minimal residual disease (MRD) testing, and AI-powered solutions like Tempus ONE, a voice-enabled device providing real-time access to patient data and clinical insights. The Tempus Next platform uses AI to optimize care pathways and close clinical gaps by analyzing EHR, imaging, and molecular data. Additionally, Tempus provides clinical trial matching and collaborates extensively with biopharma for drug discovery and research.